Why the study?
NAFLD and cirrhosis are often diagnosed using invasive methods like liver biopsy, creating a need for non-invasive biomarkers to improve early detection and management.
Key points are not available for this paper at this time.
Population
Patients with NAFLD and cirrhosis
Comparison
Procalcitonin and Mean Platelet Volume levels evaluated against hepatic steatosis
Background: Non-alcoholic fatty liver disease (NAFLD) and cirrhosis represent significant global health concerns, often diagnosed through invasive methods like liver biopsy. Identifying non-invasive biomarkers for these conditions could greatly enhance early detection and management. Objective: To evaluate the relationship between Procalcitonin (PCT) and Mean Platelet Volume (MPV) levels and hepatic steatosis in patients with NAFLD and cirrhosis.
No takes yet. Share an insight, caveat, or question.
Gadallah et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: